Key result
Initiating low-dose aspirin administration prior to 20 weeks of gestation significantly reduces the incidence of preeclampsia in pregnant women.
Why the study?
Numerous randomized trials have shown variable effects of aspirin on the incidence of preeclampsia, prompting an evaluation of its efficacy for preeclampsia prevention.
Does low-dose aspirin reduce the incidence of preeclampsia in pregnant women?
Systematic Review (n=23,435)
Does low-dose aspirin reduce the incidence of preeclampsia in pregnant women?
Low-dose aspirin administration prior to 20 weeks of gestation appears to reduce the incidence of preeclampsia, though results across recent studies are heterogeneous.
Supports early low-dose aspirin for preeclampsia prevention; confirms benefit yet highlights heterogeneity in recent data.
Background: Numerous randomized trials have reported the efficacy and safety of aspirin use during pregnancy and the variable effects of aspirin on the incidence of preeclampsia. Aim: This study aims to summarize and evaluate the efficacy of aspirin in preventing preeclampsia. Methods: A systematic search strategy was conducted across several electronic reference databases (PubMed, Cochrane Library, Google Scholar) and included articles published between 2019–2023. Duplicate publications, review articles, editorials, and incomplete articles were excluded. Results: Database searches identified a total of 92.832 articles. Of these, 100 articles passed the screening process, resulting in 22 articles for full-text assessment. Among them, 12 articles did not evaluate the outcome of interest. Hence, we found 10 appropriate studies included. Conclusion: Low-dose aspirin administration prior to 20 weeks of gestation reduces the incidence of preeclampsia significantly. However, additional research is required to investigate the long-term efficacy and safety of low-dose aspirin administration during pregnancy by assessing the long-term outcomes in expectant women and their infants.
No takes yet. Share an insight, caveat, or question.
Revynca Petronella (2023) conducted a systematic review in Preeclampsia (n=23,435). Aspirin vs. Placebo or control was evaluated on Incidence of preeclampsia. Initiating low-dose aspirin administration prior to 20 weeks of gestation significantly reduces the incidence of preeclampsia in pregnant women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: